|
| 36480349 | A Qualitative Study of the Factors Influencing Patients' Experience of Soft Tissue Sarcoma in the United Kingdom. | Cancer Nurs | 2024 |
| 37568761 | Patients' Experiences of a Sarcoma Diagnosis: A Process Mapping Exercise of Diagnostic Pathways. | Cancers (Basel) | 2023 |
| 37730384 | Young people's opinions of cancer care in England: the BRIGHTLIGHT cohort. | BMJ Open | 2023 |
| 34767314 | Current approaches to management of bone sarcoma in adolescent and young adult patients. | Pediatr Blood Cancer | 2022 |
| 35635934 | Survival after high-dose chemotherapy for refractory and recurrent Ewing sarcoma. | Eur J Cancer | 2022 |
| 35689897 | Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma. | Eur J Cancer | 2022 |
| 36522207 | Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial. | Lancet | 2022 |
| 36347760 | Erratum to 'Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma' [Eur J Cancer 170 (2022) 209-235]. | Eur J Cancer | 2022 |
| 35190694 | Associations between diagnostic time intervals and health-related quality of life, clinical anxiety and depression in adolescents and young adults with cancer: cross-sectional analysis of the BRIGHTLIGHT cohort. | Br J Cancer | 2022 |
| 35246418 | Disease progression in osteosarcoma: a multistate model for the EURAMOS-1 (European and American Osteosarcoma Study) randomised clinical trial. | BMJ Open | 2022 |
| 33289920 | SARC025 arms 1 and 2: A phase 1 study of the poly(ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma. | Cancer | 2021 |
| 33827838 | Processes of care and survival associated with treatment in specialist teenage and young adult cancer centres: results from the BRIGHTLIGHT cohort study. | BMJ Open | 2021 |
| 34247435 | Reporting the whole story: Analysis of the 'out-of-scope' questions from the James Lind Alliance Teenage and Young Adult Cancer Priority Setting Partnership Survey. | Health Expect | 2021 |
| 34050156 | Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden. | Nat Commun | 2021 |
| 31895170 | The BRIGHTLIGHT National Survey of the Impact of Specialist Teenage and Young Adult Cancer Care on Caregivers' Information and Support Needs. | Cancer Nurs | 2021 |
| 32227293 | Development of a patient-reported experience questionnaire for patients with sarcoma: the Sarcoma Assessment Measure (SAM). | Qual Life Res | 2020 |
| 31841739 | Renegotiation of identity in young adults with cancer: A longitudinal narrative study. | Int J Nurs Stud | 2020 |
| 31952545 | International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol. | Trials | 2020 |
| 33243793 | Longitudinal cohort study of the impact of specialist cancer services for teenagers and young adults on quality of life: outcomes from the BRIGHTLIGHT study. | BMJ Open | 2020 |
| 33212978 | Continuous 14 Day Infusional Ifosfamide for Management of Soft-Tissue and Bone Sarcoma: A Single Centre Retrospective Cohort Analysis. | Cancers (Basel) | 2020 |
| 33292535 | Seeking international consensus on approaches to primary tumour treatment in Ewing sarcoma. | Clin Sarcoma Res | 2020 |
| 32880648 | Association of Self-reported Presenting Symptoms With Timeliness of Help-Seeking Among Adolescents and Young Adults With Cancer in the BRIGHTLIGHT Study. | JAMA Netw Open | 2020 |
| 32789023 | BRIGHTLIGHT researchers as 'dramaturgs': creating <i>There is a Light</i> from complex research data. | Res Involv Engagem | 2020 |
| 30685685 | Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. | Eur J Cancer | 2019 |
| 29916309 | Marginal structural models with dose-delay joint-exposure for assessing variations to chemotherapy intensity. | Stat Methods Med Res | 2019 |
| 29978324 | Health professional perceptions of communicating with adolescents and young adults about bone cancer clinical trial participation. | Support Care Cancer | 2019 |
| 31383701 | Research priorities for young people with cancer: a UK priority setting partnership with the James Lind Alliance. | BMJ Open | 2019 |
| 31553693 | High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008. | J Clin Oncol | 2019 |
| 31551374 | Qualitative study exploring patients experiences of being diagnosed and living with primary bone cancer in the UK. | BMJ Open | 2019 |
| 31573951 | Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy. | JMIR Res Protoc | 2019 |
| 31152023 | Method to measure the mismatch between target and achieved received dose intensity of chemotherapy in cancer trials: a retrospective analysis of the MRC BO06 trial in osteosarcoma. | BMJ Open | 2019 |
| 31005941 | Description of the BRIGHTLIGHT cohort: the evaluation of teenage and young adult cancer services in England. | BMJ Open | 2019 |
| 30911268 | A Critical Review of the Impact of Sarcoma on Psychosocial Wellbeing. | Sarcoma | 2019 |
| 30879111 | A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup. | Cancer Chemother Pharmacol | 2019 |
| 30288560 | The current status of MRI in the pre-operative assessment of intramedullary conventional appendicular osteosarcoma. | Skeletal Radiol | 2019 |
| 30507003 | Patient perspectives on a national multidisciplinary team meeting for a rare cancer. | Eur J Cancer Care (Engl) | 2019 |
| 30696681 | Understanding care when cure is not likely for young adults who face cancer: a realist analysis of data from patients, families and healthcare professionals. | BMJ Open | 2019 |
| 26936110 | The perceptions of teenagers, young adults and professionals in the participation of bone cancer clinical trials. | Eur J Cancer Care (Engl) | 2018 |
| 30188977 | Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Ann Oncol | 2018 |
| 30188789 | High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008. | J Clin Oncol | 2018 |
| 30179828 | Survival of adults with cancers of bone or soft tissue in Europe-Report from the EUROCARE-5 study. | Cancer Epidemiol | 2018 |
| 29902785 | Dedifferentiated Chondrosarcoma Demonstrating Osteosarcomatous Differentiation. | Oncol Res Treat | 2018 |
| 29846513 | Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Ann Oncol | 2018 |
| 29846498 | Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Ann Oncol | 2018 |
| 30498386 | Conceptualizing age-appropriate care for teenagers and young adults with cancer: a qualitative mixed-methods study. | Adolesc Health Med Ther | 2018 |
| 30607259 | Involving young people in BRIGHTLIGHT from study inception to secondary data analysis: insights from 10â¿¿years of user involvement. | Res Involv Engagem | 2018 |
| 30285218 | Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Ann Oncol | 2018 |
| 30285214 | Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Ann Oncol | 2018 |
| 30333006 | Age-related sarcoma patient experience: results from a national survey in England. | BMC Cancer | 2018 |
| 29503844 | Diagnostic timeliness in adolescents and young adults with cancer: a cross-sectional analysis of the BRIGHTLIGHT cohort. | Lancet Child Adolesc Health | 2018 |